Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Curative Biosciences Inc CBDX

Curative Biosciences, Inc., formerly Amaize Beverage Corporation, is a life sciences company focused on developing and commercializing novel therapeutics using hemp-derived CBD (hemp derived Cannabidiol). The Company’s product segment is focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors. The Company through its consumer products business... see more

GREY:CBDX - Post Discussion

Curative Biosciences Inc > Biden Will Send CBDX On Parabolic Run
View:
Post by Djoy1002 on Jan 27, 2021 1:26pm

Biden Will Send CBDX On Parabolic Run

Canbud is highly optimistic about the democratic control of the congress, it would provide a potential for a great need of medical cannabis demand in the US and around the world. Biden has voiced his support for cannabis decriminalization during his election campaign.
 
Click Here For Article According to Research and Markets, the world's largest market research store, publication in October 2020, Global CBD Oil & CBD Consumer Health Market 2020, "The global CBD oil and CBD consumer health market size is expected to reach USD 123.2 billion by 2027, expanding at a CAGR of 25.6% over the forecast period."
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities